Direct Impact

Concepts for which ROBERT O DILLMAN has direct influence:

monoclonal antibody
autologous tumor
indolent lymphoma
interferon alfa
cancer cells
stage iii
chronic lymphocytic

External impact

Concepts related to the work of other authors for which ROBERT O DILLMAN has influence:

late reactions
sphenoid sinus
metallic foreign bodies
lead intoxication
bullet lodged
surgical removal
arquebus wounds

Prominent publications by ROBERT O. DILLMAN

KOL-Index: 17 Measurement of several urinary metabolites of hydroxylysine indicates that considerable collagen degradation occurred in four individuals immediately after they had inhaled concentrated ammonia vapors. Since clinical and/or radiological evidence of intense upper respiratory and pulmonary inflammation were evident, it is likely that collagen degradation occurred at the level of the respiratory system.
Known for
Degradation Occurred
KOL-Index: 16 A man was hospitalized on three occasions for symptoms of lead intoxication 20 to 25 years after a gunshot wound that resulted in retention of a lead bullet in his hip joint. The potential for lead toxicity as a complication of a lead missile injury appears to be related to (1) the surface area of lead exposed for dissolution, (2) the location of the lead projectile, and (3) the length of ...
Known for
Fluid Dissolution | Complication Lead | Intoxication Gunshot
KOL-Index: 2 RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of isotretinoin may be an effective way to prevent cancer or stop cancer from growing. Interferon alfa may interfere with the growth of cancer cells. Combining isotretinoin and interferon may be an effective treatment for some recurrent cancers.PURPOSE: Phase II ...
Known for
Recurrent Cancers | Oral Isotretinoin
KOL-Index: 2 RATIONALE: Monoclonal antibodies can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy and monoclonal antibody therapy may kill more cancer cells.PURPOSE: Phase II trial to study the ...
Known for
Killing Substances | Antibody Receive | Deliver Cancer | Antibodies Locate
KOL-Index: 2 RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining different types of biological therapies, including interferon alfa, interleukin-2, and tumor infiltrating lymphocytes, may kill more cancer cells.PURPOSE: Phase II trial to study the effectiveness of biological therapies, including interferon alfa, interleukin-2, ...
Known for
Therapies Ways | Receive Ifn | Lymphocytes Treating | Criteria Regimen
KOL-Index: 2 RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Combining the monoclonal antibody rituximab with dexamethasone may kill more cancer cells.PURPOSE: Phase II trial to study the effectiveness of rituximab and dexamethasone in treating patients with recurrent or refractory indolent ...
Known for
Rate Survival | Cells Combining | Response Duration | Tumor Killing
KOL-Index: 2 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining interferon alfa or the monoclonal antibody rituximab with chemotherapy may kill more cancer cells.PURPOSE: Phase II trial to compare the effectiveness of combination chemotherapy plus interferon alfa or rituximab in treating patients who have high risk stage III ...
Known for
Oral Prednisone | Cells Phase | Combining Interferon | Dividing Growing
KOL-Index: 2 RATIONALE: Vaccines made from the patient's cancer cells may make the body build an immune response and kill their tumor cells.PURPOSE: Randomized phase II trial to study the effectiveness of autologous tumor cell vaccination plus immunologic adjuvant in treating patients who have metastatic cancer. Detailed Description OBJECTIVES: I. Determine the toxic effects and side effects associated ...
Known for
Vaccine Treating | Kill Tumor | Gamma Continuing | Build Immune
KOL-Index: 2 RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. Biological therapies such as interferon alfa-2b use different ways to stimulate the immune system and stop cancer cells from growing.PURPOSE: Phase II trial to study the effectiveness of rituximab or interferon alfa-2b in ...
Known for
Biological Therapies | Receive Rituximab | Months Arm | Alfa-2b Treating
KOL-Index: 2 RATIONALE: Interferon alfa may interfere with the growth of cancer cells. Interleukin-2 may stimulate a person's white blood cells to kill kidney cancer or melanoma cells.PURPOSE: Phase II trial to study the effectiveness of high-dose interferon alfa and interleukin-2 in treating patients with metastatic kidney cancer or melanoma. Detailed Description OBJECTIVES: I. Determine the safety, ...
Known for
Bolus Infusions

https://www.g2.com/products/key-opinion-leaders-kols/reviews https://www.bbb.org/us/fl/doral/profile/data-analytics/key-opinion-leaders-0633-92023858 https://www.trustpilot.com/review/keyopinionleaders.com https://www.yelp.com/biz/key-opinion-leaders-miami


© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172